Sumitomo Mitsui DS Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-89,130	Closed	-$807K	–	759
2016 Q4	$807K	Sell	89,130 -500	-0.6%	-$4.65K	0.02%	500
2016 Q3	$832K	Sell	89,630 -17,500	-16%	-$167K	0.02%	502
2016 Q2	$1.1M	Sell	107,130 -266,785	-71%	-$2.45M	0.03%	380
2016 Q1	$3.38M	Buy	373,915 +55,485	+17%	+$496K	0.1%	190
2015 Q4	$2.95M	Buy	318,430 +265,870	+506%	+$2.91M	0.1%	198
2015 Q3	$671K	Buy	+52,560	New	+$653K	0.02%	520
2014 Q2	–	Sell	-24,500	Closed	-$215K	–	786
2014 Q1	$215K	Hold	24,500	–	–	0.01%	773
2013 Q4	$201K	Buy	+24,500	New	+$194K	0.01%	777

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's RDY Position: Q1 2017 in Review

Sumitomo Mitsui DS Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 89,130 shares — an estimated $807K sold.

Sumitomo Mitsui DS Asset Management first reported a position in RDY in Q4 2013 and held it in 8 quarters. The position peaked at $3.38M in Q1 2016. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

Sumitomo Mitsui DS Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
Sumitomo Mitsui DS Asset Management sold 89,130 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $807K.
Sumitomo Mitsui DS Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 8 quarters.
Sumitomo Mitsui DS Asset Management's Dr. Reddy's Laboratories position peaked at $3.38M in Q1 2016.
134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q1 2017, filed 28 Apr 2017.